Shizheng Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Shizheng Huang has a total of 169 co-authors. Here are the top co-authors by number of shared publications:
- Katalin Susztak
Department of Medicine, Renal Electrolyte and Hypertension Division, Perelman School of Medicine, University of Pennsylvania
11 shared publications - Chengxiang Qiu
Department of Molecular and Systems Biology, Dartmouth College, Hanover, NH, USA
5 shared publications - Jihwan Park
School of Life Sciences, Gwangju Institute of Science and Technology (GIST), Gwangju, Korea
4 shared publications - Xiaoyan Zhang
Health Science Center, East China Normal University, Shanghai, China
4 shared publications Yi-An Ko
Department of Medicine Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
4 shared publications- Christopher D. Brown
Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
3 shared publications
Latest Publications
- Open Access
- 5 November 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (45)
Genome-wide association studies identify the role of caspase-9 in kidney disease
Integrated omics analysis (GWAS, eQTL, snATAC, and mouse genetic models) identified caspase-9 as a kidney disease risk gene.
- 5 November 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (45)
Open AccessGenome-wide association studies identify the role of caspase-9 in kidney disease
Integrated omics analysis (GWAS, eQTL, snATAC, and mouse genetic models) identified caspase-9 as a kidney disease risk gene.
- 13 January 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 13 (576)
Kidney disease genetic risk variants alter lysosomal beta-mannosidase ( MANBA ) expression and disease severity
MANBA is a kidney disease risk gene that alters tubular endolysosomal function, inducing inflammasome activation and fibrosis.
- 13 January 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 13 (576)
Kidney disease genetic risk variants alter lysosomal beta-mannosidase ( MANBA ) expression and disease severity
MANBA is a kidney disease risk gene that alters tubular endolysosomal function, inducing inflammasome activation and fibrosis.
- Open Access
Renal proximal tubule cell state and metabolism are coupled by nuclear receptors
Kidney disease development is poorly understood due to the complex cellular interactions of more than 25 different cell types, each with specialized functions. Here, we used single cell RNA-sequencing to resolve cell type-specific and cell fraction changes in kidney disease. Whole kidney RNA-sequencing results were strongly influenced by cell fraction changes, but minimally informative to detect cell type-specific gene expression changes. Cell type-specific differential expression analysis identified proximal tubule cells (PT cells) as the key vulnerable cell type in diseased kidneys. Through unbiased cell trajectory analyses, we show that PT cell differentiation state is altered in disease state. Lipid metabolism (fatty acid oxidation and oxidative phosphorylation) in PT cells showed the strongest and reproducible association with PT cells state. The coupling of cell state and metabolism is established by nuclear receptors such as PPARA and ESRRA that not only control cellular metabolism but also the expression of PT cell-specific genes in mice and patient samples.
Open AccessRenal proximal tubule cell state and metabolism are coupled by nuclear receptors
Kidney disease development is poorly understood due to the complex cellular interactions of more than 25 different cell types, each with specialized functions. Here, we used single cell RNA-sequencing to resolve cell type-specific and cell fraction changes in kidney disease. Whole kidney RNA-sequencing results were strongly influenced by cell fraction changes, but minimally informative to detect cell type-specific gene expression changes. Cell type-specific differential expression analysis identified proximal tubule cells (PT cells) as the key vulnerable cell type in diseased kidneys. Through unbiased cell trajectory analyses, we show that PT cell differentiation state is altered in disease state. Lipid metabolism (fatty acid oxidation and oxidative phosphorylation) in PT cells showed the strongest and reproducible association with PT cells state. The coupling of cell state and metabolism is established by nuclear receptors such as PPARA and ESRRA that not only control cellular metabolism but also the expression of PT cell-specific genes in mice and patient samples.
- Top Cited Papers
- 1 October 2018
- Published by Springer Nature in Nature Medicine
- Vol. 24 (11) , 1721-1731
Renal compartment–specific genetic variation analyses identify new pathways in chronic kidney disease
Chronic kidney disease (CKD), a condition in which the kidneys are unable to clear waste products, affects 700 million people globally. Genome-wide association studies (GWASs) have identified sequence variants for CKD; however, the biological basis of these GWAS results remains poorly understood. To address this issue, we created an expression quantitative trait loci (eQTL) atlas for the glomerular and tubular compartments of the human kidney. Through integrating the CKD GWAS with eQTL, single-cell RNA sequencing and regulatory region maps, we identified novel genes for CKD. Putative causal genes were enriched for proximal tubule expression and endolysosomal function, where DAB2, an adaptor protein in the TGF-β pathway, formed a central node. Functional experiments confirmed that reducing Dab2 expression in renal tubules protected mice from CKD. In conclusion, compartment-specific eQTL analysis is an important avenue for the identification of novel genes and cellular pathways involved in CKD development and thus potential new opportunities for its treatment.
- 1 October 2018
- Published by Springer Nature in Nature Medicine
- Vol. 24 (11) , 1721-1731
Top Cited PapersRenal compartment–specific genetic variation analyses identify new pathways in chronic kidney disease
Chronic kidney disease (CKD), a condition in which the kidneys are unable to clear waste products, affects 700 million people globally. Genome-wide association studies (GWASs) have identified sequence variants for CKD; however, the biological basis of these GWAS results remains poorly understood. To address this issue, we created an expression quantitative trait loci (eQTL) atlas for the glomerular and tubular compartments of the human kidney. Through integrating the CKD GWAS with eQTL, single-cell RNA sequencing and regulatory region maps, we identified novel genes for CKD. Putative causal genes were enriched for proximal tubule expression and endolysosomal function, where DAB2, an adaptor protein in the TGF-β pathway, formed a central node. Functional experiments confirmed that reducing Dab2 expression in renal tubules protected mice from CKD. In conclusion, compartment-specific eQTL analysis is an important avenue for the identification of novel genes and cellular pathways involved in CKD development and thus potential new opportunities for its treatment.
- Open Access
- 18 September 2018
- Published by Public Library of Science (PLoS) in PLOS Biology
- Vol. 16 (9) , e2005233
Jagged1/Notch2 controls kidney fibrosis via Tfam-mediated metabolic reprogramming
While Notch signaling has been proposed to play a key role in fibrosis, the direct molecular pathways targeted by Notch signaling and the precise ligand and receptor pair that are responsible for kidney disease remain poorly defined. In this study, we found that JAG1 and NOTCH2 showed the strongest correlation with the degree of interstitial fibrosis in a genome-wide expression analysis of a large cohort of human kidney samples. Transcript analysis of mouse kidney disease models, including folic-acid (FA)–induced nephropathy, unilateral ureteral obstruction (UUO), or apolipoprotein L1 (APOL1)-associated kidney disease, indicated that Jag1 and Notch2 levels were higher in all analyzed kidney fibrosis models. Mice with tubule-specific deletion of Jag1 or Notch2 (Kspcre/Jag1flox/flox and Kspcre/Notch2flox/flox) had no kidney-specific alterations at baseline but showed protection from FA-induced kidney fibrosis. Tubule-specific genetic deletion of Notch1 and global knockout of Notch3 had no effect on fibrosis. In vitro chromatin immunoprecipitation experiments and genome-wide expression studies identified the mitochondrial transcription factor A (Tfam) as a direct Notch target. Re-expression of Tfam in tubule cells prevented Notch-induced metabolic and profibrotic reprogramming. Tubule–specific deletion of Tfam resulted in fibrosis. In summary, Jag1 and Notch2 play a key role in kidney fibrosis development by regulating Tfam expression and metabolic reprogramming. Chronic kidney disease (CKD) is the ninth leading cause of death in the United States. Kidney fibrosis usually occurs at the final stage of the disease. The Notch signaling pathway is a cell–cell communication pathway, that activated by a ligand (expressed on the signal-sending cell) interacting with and inducing the breakdown of the Notch receptor on the receiving cell. We previously established that Notch signaling in renal tubular epithelial cells (RTECs) plays a key role in kidney fibrosis development. However, the precise ligand and receptor pair that contributes to kidney fibrosis remain unknown. Here, we performed a systematic analysis to define the specific molecular pathways of Notch-induced fibrosis development in RTECs. We found that Jag1 acting together with Notch2 leads to metabolic reprogramming of RTECs via mitochondrial transcription factor A (Tfam), resulting in cell proliferation and dedifferentiation and fibrosis development. Our study suggests that targeting JAG1 or NOTCH2 may have important therapeutic potential for treatment of CKD.
- 18 September 2018
- Published by Public Library of Science (PLoS) in PLOS Biology
- Vol. 16 (9) , e2005233
Open AccessJagged1/Notch2 controls kidney fibrosis via Tfam-mediated metabolic reprogramming
While Notch signaling has been proposed to play a key role in fibrosis, the direct molecular pathways targeted by Notch signaling and the precise ligand and receptor pair that are responsible for kidney disease remain poorly defined. In this study, we found that JAG1 and NOTCH2 showed the strongest correlation with the degree of interstitial fibrosis in a genome-wide expression analysis of a large cohort of human kidney samples. Transcript analysis of mouse kidney disease models, including folic-acid (FA)–induced nephropathy, unilateral ureteral obstruction (UUO), or apolipoprotein L1 (APOL1)-associated kidney disease, indicated that Jag1 and Notch2 levels were higher in all analyzed kidney fibrosis models. Mice with tubule-specific deletion of Jag1 or Notch2 (Kspcre/Jag1flox/flox and Kspcre/Notch2flox/flox) had no kidney-specific alterations at baseline but showed protection from FA-induced kidney fibrosis. Tubule-specific genetic deletion of Notch1 and global knockout of Notch3 had no effect on fibrosis. In vitro chromatin immunoprecipitation experiments and genome-wide expression studies identified the mitochondrial transcription factor A (Tfam) as a direct Notch target. Re-expression of Tfam in tubule cells prevented Notch-induced metabolic and profibrotic reprogramming. Tubule–specific deletion of Tfam resulted in fibrosis. In summary, Jag1 and Notch2 play a key role in kidney fibrosis development by regulating Tfam expression and metabolic reprogramming. Chronic kidney disease (CKD) is the ninth leading cause of death in the United States. Kidney fibrosis usually occurs at the final stage of the disease. The Notch signaling pathway is a cell–cell communication pathway, that activated by a ligand (expressed on the signal-sending cell) interacting with and inducing the breakdown of the Notch receptor on the receiving cell. We previously established that Notch signaling in renal tubular epithelial cells (RTECs) plays a key role in kidney fibrosis development. However, the precise ligand and receptor pair that contributes to kidney fibrosis remain unknown. Here, we performed a systematic analysis to define the specific molecular pathways of Notch-induced fibrosis development in RTECs. We found that Jag1 acting together with Notch2 leads to metabolic reprogramming of RTECs via mitochondrial transcription factor A (Tfam), resulting in cell proliferation and dedifferentiation and fibrosis development. Our study suggests that targeting JAG1 or NOTCH2 may have important therapeutic potential for treatment of CKD.
- Top Cited Papers
- 18 May 2018
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 360 (6390) , 758-763
Single-cell transcriptomics of the mouse kidney reveals potential cellular targets of kidney disease
Touring the kidney, cell by cell: Our kidneys play a critical role in keeping us healthy, a fact of which we are reminded several times each day. This organ's cellular complexity has hindered progress in understanding the mechanisms underlying chronic kidney disease, which affects 10% of the world's population. Using single-cell transcriptional profiling, Park et al. produced a comprehensive cell atlas of the healthy mouse kidney (see the Perspective by Humphreys). An unexpected cell type in the collecting duct appears to be a transitional state between two known cell types. The transition from one cell type to the other is regulated by the Notch signaling pathway and is associated with metabolic acidosis. The authors also find that genetically distinct kidney diseases with common clinical features share common cellular origins. Science , this issue p. 758 ; see also p. 709
- 18 May 2018
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 360 (6390) , 758-763
Top Cited PapersSingle-cell transcriptomics of the mouse kidney reveals potential cellular targets of kidney disease
Touring the kidney, cell by cell: Our kidneys play a critical role in keeping us healthy, a fact of which we are reminded several times each day. This organ's cellular complexity has hindered progress in understanding the mechanisms underlying chronic kidney disease, which affects 10% of the world's population. Using single-cell transcriptional profiling, Park et al. produced a comprehensive cell atlas of the healthy mouse kidney (see the Perspective by Humphreys). An unexpected cell type in the collecting duct appears to be a transitional state between two known cell types. The transition from one cell type to the other is regulated by the Notch signaling pathway and is associated with metabolic acidosis. The authors also find that genetically distinct kidney diseases with common clinical features share common cellular origins. Science , this issue p. 758 ; see also p. 709
- 8 May 2018
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 115 (21) , 5600-5605
Farnesoid X receptor is essential for the survival of renal medullary collecting duct cells under hypertonic stress
Significance: As a ligand-activated transcription factor, farnesoid X receptor (FXR) is abundantly expressed in the liver and small intestine, where it plays an important role in the maintenance of bile acid, lipid, and glucose homeostasis. Increasing evidence is emerging that FXR may be a critical regulatory factor in renal physiology and pathophysiology. The present study demonstrates an essential role of FXR in promoting cell survival of medullary collecting duct cells under hypertonic stress and identifies FXR-induced TonEBP expression and activation as an underlying mechanism. This work provides an insight into the role of FXR in renal urine concentration.
- 8 May 2018
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 115 (21) , 5600-5605
Farnesoid X receptor is essential for the survival of renal medullary collecting duct cells under hypertonic stress
Significance: As a ligand-activated transcription factor, farnesoid X receptor (FXR) is abundantly expressed in the liver and small intestine, where it plays an important role in the maintenance of bile acid, lipid, and glucose homeostasis. Increasing evidence is emerging that FXR may be a critical regulatory factor in renal physiology and pathophysiology. The present study demonstrates an essential role of FXR in promoting cell survival of medullary collecting duct cells under hypertonic stress and identifies FXR-induced TonEBP expression and activation as an underlying mechanism. This work provides an insight into the role of FXR in renal urine concentration.
- 1 June 2017
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 100 (6) , 940-953
Genetic-Variation-Driven Gene-Expression Changes Highlight Genes with Important Functions for Kidney Disease
- 1 June 2017
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 100 (6) , 940-953
Genetic-Variation-Driven Gene-Expression Changes Highlight Genes with Important Functions for Kidney Disease
- 1 April 2017
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 312 (4) , F619-F628
Liver X receptor β increases aquaporin 2 protein level via a posttranscriptional mechanism in renal collecting ducts
Liver X receptors (LXRs) including LXRα and LXRβ are nuclear receptor transcription factors and play an important role in lipid and glucose metabolism. It has been previously reported that mice lacking LXRβ but not LXRα develop a severe urine concentrating defect, likely via a central mechanism. Here we provide evidence that LXRβ regulates water homeostasis through increasing aquaporin 2 (AQP2) protein levels in renal collecting ducts. LXRβ−/− mice exhibited a reduced response to desmopressin (dDAVP) stimulation, suggesting that the diabetes insipidus phenotype is of both central and nephrogenic origin. AQP2 protein abundance in the renal inner medulla was significantly reduced in LXRβ−/− mice but with little change in AQP2 mRNA levels. In vitro studies showed that AQP2 protein levels were elevated upon LXR agonist treatment in both primary cultured mouse inner medullary duct cells (mIMCD) and the mIMCD3 cell line with stably expressed AQP2. In addition, LXR agonists including TO901317 and GW3965 failed to induce AQP2 gene transcription but diminished its protein ubiquitination in primary cultured mIMCD cells, thereby inhibiting its degradation. Moreover, LXR activation-induced AQP2 protein expression was abolished by the protease inhibitor MG132 and the ubiquitination-deficient AQP2 (K270R). Taken together, the present study demonstrates that activation of LXRβ increases AQP2 protein levels in the renal collecting ducts via a posttranscriptional mechanism. As such, LXRβ represents a key regulator of body water homeostasis.
- 1 April 2017
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 312 (4) , F619-F628
Liver X receptor β increases aquaporin 2 protein level via a posttranscriptional mechanism in renal collecting ducts
Liver X receptors (LXRs) including LXRα and LXRβ are nuclear receptor transcription factors and play an important role in lipid and glucose metabolism. It has been previously reported that mice lacking LXRβ but not LXRα develop a severe urine concentrating defect, likely via a central mechanism. Here we provide evidence that LXRβ regulates water homeostasis through increasing aquaporin 2 (AQP2) protein levels in renal collecting ducts. LXRβ−/− mice exhibited a reduced response to desmopressin (dDAVP) stimulation, suggesting that the diabetes insipidus phenotype is of both central and nephrogenic origin. AQP2 protein abundance in the renal inner medulla was significantly reduced in LXRβ−/− mice but with little change in AQP2 mRNA levels. In vitro studies showed that AQP2 protein levels were elevated upon LXR agonist treatment in both primary cultured mouse inner medullary duct cells (mIMCD) and the mIMCD3 cell line with stably expressed AQP2. In addition, LXR agonists including TO901317 and GW3965 failed to induce AQP2 gene transcription but diminished its protein ubiquitination in primary cultured mIMCD cells, thereby inhibiting its degradation. Moreover, LXR activation-induced AQP2 protein expression was abolished by the protease inhibitor MG132 and the ubiquitination-deficient AQP2 (K270R). Taken together, the present study demonstrates that activation of LXRβ increases AQP2 protein levels in the renal collecting ducts via a posttranscriptional mechanism. As such, LXRβ represents a key regulator of body water homeostasis.
- Open Access
- 1 January 2017
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 292 (3) , 837-846
Notch Pathway Is Activated via Genetic and Epigenetic Alterations and Is a Therapeutic Target in Clear Cell Renal Cancer
- 1 January 2017
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 292 (3) , 837-846
Open AccessNotch Pathway Is Activated via Genetic and Epigenetic Alterations and Is a Therapeutic Target in Clear Cell Renal Cancer